![](/img/cover-not-exists.png)
P374 Effects of subcutaneous vedolizumab on health-related quality of life and work productivity in patients with ulcerative colitis: results from the Phase 3 VISIBLE 1 trial
Vermeire, S, Krznarić, Ž, Kobayashi, T, Chen, J, Agboton, C, Kisfalvi, K, Patel, H, Sandborn, WVolume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.498
Date:
January, 2019
File:
PDF, 1.37 MB
english, 2019